Replies to post #48776 on Biotech Values

[DewDiligence]

>How is COLY an example of this program-survival bias thingy?<

Program-survival bias is a shorthand way of saying that the efficacy observed in phase-2 programs that advance to phase-3 is biased on the high side relative to the true efficacy of the drugs in question. Clearly, this turned out to be the case with COLY’s drug.